Links

Homepage

Stock List

Search by Ticker

News

Login

Edwards Lifesciences Corporatio (NYSE:EW)
Stock Analysis

EW83.1
▼ -1.04%-0.87

Stock Analysis

The following stock analysis is based on 7.4 years of data (i.e. since Sep 20, 2013). All the stock history has been downloaded.

Stock Exchange

Edwards Lifesciences Corporatio trades on the NYSE exchange in USD dollars.

Sector

It is in the healthcare sector.

Current Status of Edwards Lifesciences Corporatio

It is currently trading at $83.1 ($83.97 the previous day).

Financials

The next reporting date is in 57 days (2021 04 27).

CNN estimates profits for the upcoming quarter will be $0.48 per share ($1.2B). The current Canada / US exchange rate is 1.27259.



Over the past 12 months, $0 worth of shares have been purchased and $94822257 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is 23.2% per year assuming steady exponential growth. The actual 5 year average is 26.66. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year78.35541187511.8- Below Average
2 year70.08044176706840.9+ Above Average
3 year49.74336134453830.4+ Above Average
4 year38.15587044534413.6- Below Average
5 year33.60106463878336.6+ Above Average
Edwards Lifesciences Corporatio is projected by analysts to get to $95.00 within the next 12 months (14.3%), but preticted targets range from as high as $111.00 (33.6%) and as low as $71(-14.6%).

Risk

The worst drop it has had in recent years is -36.2%. It has a steady shape to the stock curve, which means the stock continues on a consistent trend except during extreme periods of volitility, but usually recovers quickly. These stocks are very safe and do not have to be checked often.

Stock shape test

DAYS AG0PRICE
1085.62DROPPING
3084.84RISING
6090.71DROPPING
15079.575RISING
36568.28RISING
80048.07RISING
120035.7RISING
160039.39DROPPING
200023.28RISING


With an average increase of 23.2% year over year, if Edwards Lifesciences Corporatio is bought at the worst time, Stockmarketizer analysts estimate it will take 18.7 months before the stock will recover to the original purchase price. The P/E value is 63.92. The stock is under valued as the industry standard in the healthcare sector is a P/E of 86.26.

Description

Edwards Lifesciences is an American medical equipment company specializing in artificial heart valves and hemodynamic monitoring. It is mostly known for a transcatheter aortic heart valve made of bovine tissue within a collapsible stainless-steel stent, deployed via catheter. Their SAPIEN product is an FDA-approved device for percutaneous aortic valve replacement.

The company was founded in 1958 and has since grown to 12,200 employees and $3.4 billion in revenue by 2017. Their headquarters is located in Irvine, California (USA). The chairman and CEO is Michael A. Mussallem. The company is part of the S&P500.

Tradingview BuySell Widget

Yahoo News Feed

Many Would Be Jealous Of Edwards Lifesciences' (NYSE:EW) Returns On Capital

Mon, 22 Feb 2021 04:49:25 To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...... Read Full Article

Edwards RESILIA Tissue Aortic Valve Demonstrates Favorable Safety and Efficacy at Five Years

Sun, 31 Jan 2021 21:51:00 Edwards Lifesciences (NYSE: EW) today announced new data from the COMMENCE clinical trial that demonstrate Edwards' bioprosthetic surgical aortic valve with the company's novel RESILIA tissue platform show favorable safety and hemodynamic performance through a median of five years follow-up. ...... Read Full Article

Analyst Estimates: Here's What Brokers Think Of Edwards Lifesciences Corporation (NYSE:EW) After Its Full-Year Report

Sat, 30 Jan 2021 07:41:34 Last week, you might have seen that Edwards Lifesciences Corporation ( NYSE:EW ) released its annual result to the...... Read Full Article

Edwards Lifesciences (EW) Q4 Earnings Fall Shy of Estimates

Thu, 28 Jan 2021 13:08:01 Despite coronavirus-led business challenges, Edwards Lifesciences (EW) witnessed robust performances in TMTT business in Q4.... Read Full Article

Edwards Lifesciences Corp (EW) Q4 2020 Earnings Call Transcript

Thu, 28 Jan 2021 02:01:44 EW earnings call for the period ending January 27, 2021.... Read Full Article

Edwards Lifesciences (EW) Q4 Earnings Lag Estimates

Wed, 27 Jan 2021 22:35:10 Edwards Lifesciences (EW) delivered earnings and revenue surprises of -5.66% and 0.71%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?... Read Full Article

This Medical Stock Called For Continued Covid Headwinds — And Tumbled

Wed, 27 Jan 2021 22:16:56 Edwards Lifesciences issued a mixed fourth-quarter report Wednesday and called for Covid-related headwinds to persist until the second half of 2021. In response, EW stock tumbled.... Read Full Article

Recap: Edwards Lifesciences Q4 Earnings

Wed, 27 Jan 2021 21:50:01 Shares of Edwards Lifesciences (NYSE:EW) decreased 4.5% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 65.75% over the past year to $0.50, which missed the estimate of $0.53. Revenue of $1,192,000,000 rose by 1.53% year over year, which ...... Read Full Article

Edwards Lifesciences Reports Fourth Quarter Results

Wed, 27 Jan 2021 21:15:00 Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended December 31, 2020.... Read Full Article

Edwards Lifesciences Corp. to Host Earnings Call

Wed, 27 Jan 2021 20:15:00 NEW YORK, NY / ACCESSWIRE / January 27, 2021 / Edwards Lifesciences Corp. (NYSE:EW) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on January 27, 2021 at 5:00 PM Eastern Time.... Read Full Article

The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement

Wed, 27 Jan 2021 12:35:59 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 26) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN) (reacted to ...... Read Full Article

Edwards Lifesciences's Earnings: A Preview

Tue, 26 Jan 2021 15:32:52 On Wednesday, January 27, Edwards Lifesciences (NYSE:EW) will release its latest earnings report. Here is Benzinga's outlook for the company. What Are Earnings, Net Income, And Earnings Per Share? Earnings and especially earnings per share (EPS) are useful measures of ...... Read Full Article

What's in Store for Edwards Lifesciences in (EW) Q4 Earnings?

Wed, 20 Jan 2021 16:52:04 Robust customer adoption of the TruWave disposable pressure monitoring devices and INSPIRIS RESILIA aortic valve is likely to have driven Edwards Lifesciences' (EW) Q4 revenues.... Read Full Article

Are Strong Financial Prospects The Force That Is Driving The Momentum In Edwards Lifesciences Corporation's NYSE:EW) Stock?

Thu, 14 Jan 2021 12:53:30 Edwards Lifesciences' (NYSE:EW) stock is up by a considerable 6.8% over the past month. Given the company's impressive...... Read Full Article

Edwards Lifesciences To Host Earnings Conference Call On January 27, 2021

Wed, 13 Jan 2021 12:05:00 Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2020 after the market closes on Wednesday, January 27, 2021, and will host a conference call at 5:00 p.m. ET that day to discuss those results.... Read Full Article

Bear of the Day: Penumbra (PEN)

Fri, 08 Jan 2021 21:25:09 Bear of the Day: Penumbra (PEN)... Read Full Article

Is Edwards Lifesciences' (NYSE:EW) 231% Share Price Increase Well Justified?

Wed, 23 Dec 2020 06:08:29 When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, if you buy shares...... Read Full Article

Edwards Treats First Patient In U.S. Clinical Trial Evaluating Minimally Invasive Device For Mitral Valve Disease

Mon, 21 Dec 2020 14:05:00 Edwards Lifesciences (NYSE: EW), today announced that the first patient has been treated in the RESTORE clinical trial, which will evaluate the safety and effectiveness of the investigational HARPOON Beating Heart Mitral Valve Repair System in the United States and ...... Read Full Article

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Canada

Fri, 18 Dec 2020 18:28:00 MISSISSAUGA, Ontario, Dec. 18, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation today announced that Health Canada has approved the expanded use of the Edwards SAPIEN 3 and SAPIEN 3 Ultra transcatheter heart valves for the transfemoral treatment of patients diagnosed with severe symptomatic aortic stenosis ...... Read Full Article

Is EW A Good Stock To Buy Now?

Tue, 15 Dec 2020 00:58:01 We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors ...... Read Full Article
<